Charles Schwab Investment Management »

Monte Rosa Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.4M 246k 5.65
2023-09-30 $1.2M 243k 4.79
2023-06-30 $1.6M 230k 6.85
2023-03-31 $1.7M 224k 7.79
2022-12-31 $1.7M 225k 7.61
2022-09-30 $1.7M 213k 8.17
2022-06-30 $1.1M 116k 9.67
2022-03-31 $1.8M 125k 14.03
2021-12-31 $1.7M 85k 20.42
2021-09-30 $1.8M 80k 22.28